EQT agrees to majority stake in clinical trial software developer CluePoints

Summit Partners and other existing shareholders are reinvesting in the Belgian business, which has an office outside Philadelphia.

12 June 2024•5 mins read
LinkedInXEmail
LinkedInXEmail

Related articles